These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Primum non nocere: prophylactic versus curative ibuprofen. Hammerman C; Kaplan M Lancet; 2004 Nov 27-Dec 3; 364(9449):1920-2. PubMed ID: 15566994 [No Abstract] [Full Text] [Related]
9. Prophylactic indomethacin: factors determining permanent ductus arteriosus closure. Narayanan M; Cooper B; Weiss H; Clyman RI J Pediatr; 2000 Mar; 136(3):330-7. PubMed ID: 10700689 [TBL] [Abstract][Full Text] [Related]
10. Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants. Schmidt B; Davis P; Moddemann D; Ohlsson A; Roberts RS; Saigal S; Solimano A; Vincer M; Wright LL; N Engl J Med; 2001 Jun; 344(26):1966-72. PubMed ID: 11430325 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic closure of the ductus arteriosus: benefits and limitations. Mercanti I; Boubred F; Simeoni U J Matern Fetal Neonatal Med; 2009; 22 Suppl 3():14-20. PubMed ID: 19925358 [TBL] [Abstract][Full Text] [Related]
12. Prophylactic indomethacin for preterm infants: a systematic review and meta-analysis. Fowlie PW; Davis PG Arch Dis Child Fetal Neonatal Ed; 2003 Nov; 88(6):F464-6. PubMed ID: 14602691 [TBL] [Abstract][Full Text] [Related]
13. Randomized indomethacin trial for prevention of intraventricular hemorrhage in very low birth weight infants. Ment LR; Duncan CC; Ehrenkranz RA; Kleinman CS; Pitt BR; Taylor KJ; Scott DT; Stewart WB; Gettner P J Pediatr; 1985 Dec; 107(6):937-43. PubMed ID: 3906073 [TBL] [Abstract][Full Text] [Related]
14. Effect of indomethacin on closure of ductus arteriosus in very-low-birthweight neonates. Godambe S; Newby B; Shah V; Shah PS Acta Paediatr; 2006 Nov; 95(11):1389-93. PubMed ID: 17062465 [TBL] [Abstract][Full Text] [Related]
16. Effects of prophylactic low-dose indomethacin on hemodynamics in very low birth weight infants. Yanowitz TD; Yao AC; Werner JC; Pettigrew KD; Oh W; Stonestreet BS J Pediatr; 1998 Jan; 132(1):28-34. PubMed ID: 9469996 [TBL] [Abstract][Full Text] [Related]
17. Should we definitively abandon prophylaxis for patent ductus arteriosus in preterm new-borns? Fanos V; Pusceddu M; Dessì A; Marcialis MA Clinics (Sao Paulo); 2011; 66(12):2141-9. PubMed ID: 22189742 [TBL] [Abstract][Full Text] [Related]
18. [Ibuprofen--a new application for pharmacological closure of patent ductus arteriosus in preterm infants. Preliminary report]. Adamska E Med Wieku Rozwoj; 2000; 4(2 Suppl 3):65-71. PubMed ID: 11328971 [TBL] [Abstract][Full Text] [Related]
19. Effects of prophylactic indomethacin in extremely low-birth-weight infants with and without adequate exposure to antenatal corticosteroids. Schmidt B; Seshia M; Shankaran S; Mildenhall L; Tyson J; Lui K; Fok T; Roberts R; Arch Pediatr Adolesc Med; 2011 Jul; 165(7):642-6. PubMed ID: 21727276 [TBL] [Abstract][Full Text] [Related]
20. Neurodevelopmental outcome with early indomethacin. Chugh K Indian Pediatr; 1997 Apr; 34(4):367-8. PubMed ID: 9332109 [No Abstract] [Full Text] [Related] [Next] [New Search]